Use of an Integrated Tool for Interpretation of Blood Glucose Data Improves Correctness of Glycemic Risk Assessment in Individuals With Type 1 and Type 2 Diabetes.
Manufacturers now incorporate blood glucose (bG) value interpretation tools into their monitoring systems; however, usability of these support tools has not been well studied. We evaluated the utility and perceived benefits of support tool use by individuals with type 1 (T1D) and type 2 diabetes (T2D).



This 3-arm, randomized, simulation study assessed the impact of use of bG value interpretation support tools on participants' ability to correctly interpret bG values, using 1 of 3 tools: a new tool that uses colored scales with target range indicator (TRI), Colors and Smiley icons (already available). Participants assessed 50 bG values without use of any tool and repeated the assessment using 1 of the 3 tool configurations. Changes in percentage of correct responses when using a support tool and user perceptions were assessed.



Data sets from 140 participants were analyzed. Increases in correct responses were seen in all study groups but most notably in the TRI group (26%, P < .001) versus the Colors (3%, P = .018) and Smiley icons (6%, P < .001) groups. Significant improvements in confidence were seen among TRI users ( P = .023) but not among other tool users ( P > .627). Most TRI users felt confident (94%), agreed the tool will help them identify high and low values (96%) and will help them to make correct insulin dosage decisions (80%).



Use of the TRI significantly increases users' ability to correctly and confidently determine their glycemic risk when self-monitoring bG levels. This suggests the tool may offer clinical value to individuals with T1D and T2D.
1 CGParkin Communications, Inc, Boulder City, NV, USA.
Christopher G
CG
Parkin
2 Use-Lab GmbH, Steinfurt, Germany.
Stephanie
S
Schwenke
2 Use-Lab GmbH, Steinfurt, Germany.
Anna Katharina
AK
Ossege
2 Use-Lab GmbH, Steinfurt, Germany.
Torsten
T
Gruchmann
D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000379:methods*; D020000:Decision Support Systems, Clinical; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D001786:Blood Glucose
SMBG; electronic decision support; insulin; self-monitoring of blood glucose; type 1 diabetes; type 2 diabetes